GB1493993A - Dietary supplement and dietary methods employing said supplement for the treatment of obesity - Google Patents
Dietary supplement and dietary methods employing said supplement for the treatment of obesityInfo
- Publication number
- GB1493993A GB1493993A GB21029/75A GB2102975A GB1493993A GB 1493993 A GB1493993 A GB 1493993A GB 21029/75 A GB21029/75 A GB 21029/75A GB 2102975 A GB2102975 A GB 2102975A GB 1493993 A GB1493993 A GB 1493993A
- Authority
- GB
- United Kingdom
- Prior art keywords
- supplement
- dietary
- obesity
- treatment
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000013589 supplement Substances 0.000 title abstract 4
- 235000015872 dietary supplement Nutrition 0.000 title abstract 3
- 208000008589 Obesity Diseases 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- 235000005911 diet Nutrition 0.000 title 1
- 230000000378 dietary effect Effects 0.000 title 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 2
- 229940088594 vitamin Drugs 0.000 abstract 2
- 229930003231 vitamin Natural products 0.000 abstract 2
- 235000013343 vitamin Nutrition 0.000 abstract 2
- 239000011782 vitamin Substances 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 abstract 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 235000020845 low-calorie diet Nutrition 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 235000005152 nicotinamide Nutrition 0.000 abstract 1
- 239000011570 nicotinamide Substances 0.000 abstract 1
- 229960003966 nicotinamide Drugs 0.000 abstract 1
- 229960003512 nicotinic acid Drugs 0.000 abstract 1
- 235000001968 nicotinic acid Nutrition 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 229960003471 retinol Drugs 0.000 abstract 1
- 235000020944 retinol Nutrition 0.000 abstract 1
- 239000011607 retinol Substances 0.000 abstract 1
- 235000020183 skimmed milk Nutrition 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 235000019157 thiamine Nutrition 0.000 abstract 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- 239000011721 thiamine Substances 0.000 abstract 1
- 235000019155 vitamin A Nutrition 0.000 abstract 1
- 239000011719 vitamin A Substances 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 229940045997 vitamin a Drugs 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
1493993 Dietary supplements A N HOWARD 28 April 1976 [16 May 1975] 21029/75 Heading A5B [Also in Division A2] A dietary supplement, contains minerals and vitamins, for use in conjunction with skimmed milk to provide a complete lowcalorie diet for the treatment of obesity in man, in which the amount of the supplement which contains a datum level of 18 mg + 9 mg iron also contains at least 182 mg sodium, at least 308 mg potassium and at least 64 mg magnesium, as well as vitamin A in an amount of at least 750 Ág retinol equivalents, at least 100 i.u. Vitamin D, at least 0.76 mg thiamine, at least 14 mg nicotinic acid (or nicotinamide), and at least 18 mg ascorbic acid, and in which the total calorie content (if any) of that amount of supplement is not greater than 200 Kcals. The supplement may also contain other vitamins and conventional additives.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB21029/75A GB1493993A (en) | 1975-05-16 | 1975-05-16 | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
CA252,288A CA1065672A (en) | 1975-05-16 | 1976-05-11 | Dietary supplement, and dietary methods employing said supplement for the treatment of obesity |
DE19762621215 DE2621215A1 (en) | 1975-05-16 | 1976-05-13 | DIAL COMPOSITION |
US05/686,594 US4237118A (en) | 1972-03-06 | 1976-05-14 | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
NL7605169A NL7605169A (en) | 1975-05-16 | 1976-05-14 | DIET COMPOSITION AND RELATED DIET PRESCRIPTION FOR THE TREATMENT OF OBESITY. |
FR7614619A FR2361878A1 (en) | 1975-05-16 | 1976-05-14 | DIETARY SUPPLEMENT AND DIETARY METHODS USING THIS SUPPLEMENT FOR THE TREATMENT OF OBESITY |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB21029/75A GB1493993A (en) | 1975-05-16 | 1975-05-16 | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1493993A true GB1493993A (en) | 1977-12-07 |
Family
ID=10155986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB21029/75A Expired GB1493993A (en) | 1972-03-06 | 1975-05-16 | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
Country Status (5)
Country | Link |
---|---|
CA (1) | CA1065672A (en) |
DE (1) | DE2621215A1 (en) |
FR (1) | FR2361878A1 (en) |
GB (1) | GB1493993A (en) |
NL (1) | NL7605169A (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2450568A1 (en) * | 1978-02-24 | 1980-10-03 | Suomen Laeaeketehdas Oy Salco | PROCESS FOR THE PREPARATION OF FOOD PRODUCTS OF WHICH THE CATIONIC COMPOSITION IS PHYSIOLOGICALLY OPTIMIZED AND PRODUCTS PREPARED ACCORDING TO THIS PROCESS |
EP0040654A2 (en) * | 1980-05-20 | 1981-12-02 | Vitapharm Pharmaceutical Pty Ltd. | Electrolyte drink concentrate |
USRE31836E (en) * | 1979-05-18 | 1985-02-19 | Efamol Limited | Pharmaceutical and dietary composition |
EP0595006A1 (en) | 1992-09-14 | 1994-05-04 | Vesta Medicines (Proprietary) Limited | Pharmaceutical and dietary compositions for the treatment and prophylaxis of metabolic disturbances in infants containing vitamin B6, folic acid and vitamin B12 |
US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
GB2353471A (en) * | 1999-07-06 | 2001-02-28 | Daniel Vigdorovich | Composition for treating obesity |
US6339085B1 (en) | 1999-03-08 | 2002-01-15 | The University Of Manitoba | Therapeutics for cardiovascular and related diseases |
US6417204B1 (en) | 2000-07-07 | 2002-07-09 | Medicure International Inc. | Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics |
US6489345B1 (en) | 1999-07-13 | 2002-12-03 | Medicure, Inc. | Treatment of diabetes and related pathologies |
US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
US6586414B2 (en) | 2000-03-28 | 2003-07-01 | Medicure International Inc. | Treatment of cerebrovascular disease |
US6605612B2 (en) | 2000-02-29 | 2003-08-12 | Medicure International Inc. | Cardioprotective phosohonates and malonates |
US6677356B1 (en) | 1999-08-24 | 2004-01-13 | Medicure International Inc. | Treatment of cardiovascular and related pathologies |
US6897228B2 (en) | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
US7812037B2 (en) | 2004-10-28 | 2010-10-12 | Medicure International, Inc. | Dual antiplatelet/anticoagulant pyridoxine analogs |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8205030A (en) * | 1982-12-29 | 1984-07-16 | Johannes Franciscus Laimboeck | FOOD AND ANTI-CARIES ACTION AND METHOD FOR THE PREPARATION THEREOF. |
FR2552631B1 (en) * | 1983-10-03 | 1990-10-19 | Meram Sa Laboratoires | MILK AND MILK PRODUCTS DEPLETED OR NOT IN CALCIUM AND ENRICHED IN MAGNESIUM |
DE4212122C2 (en) * | 1992-04-10 | 1999-07-29 | Hesch Rolf Dieter Prof Dr Med | Dietary low-energy food to support medical and non-medical measures against osteoporosis |
BE1006217A6 (en) * | 1992-09-10 | 1994-06-14 | Steils Anne Epouse Gerome | Milky drink enhanced nutrient. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB810813A (en) * | 1955-11-11 | 1959-03-25 | Glaxo Lab Ltd | Improvements in or relating to human dietary preparations |
US3219454A (en) * | 1961-06-15 | 1965-11-23 | Borden Co | Low calorie diet |
IT945910B (en) * | 1971-04-08 | 1973-05-10 | Erra C Spa | DIET PRODUCT THAT CAN BE USED AS AN INTERGRATOR OF HUMAN FOOD WITH PARTICULAR REFERENCE TO CHILDHOOD, CONVALESCENCE OF PREGNANCY FROM LACTATION AND BREAST AGE AND PROCEDURES FOR ITS MANUFACTURING |
GB1356370A (en) * | 1972-03-06 | 1974-06-12 | Howard A N | Methods and formulations for the treatment of obesity |
-
1975
- 1975-05-16 GB GB21029/75A patent/GB1493993A/en not_active Expired
-
1976
- 1976-05-11 CA CA252,288A patent/CA1065672A/en not_active Expired
- 1976-05-13 DE DE19762621215 patent/DE2621215A1/en not_active Ceased
- 1976-05-14 FR FR7614619A patent/FR2361878A1/en active Granted
- 1976-05-14 NL NL7605169A patent/NL7605169A/en active Search and Examination
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2450568A1 (en) * | 1978-02-24 | 1980-10-03 | Suomen Laeaeketehdas Oy Salco | PROCESS FOR THE PREPARATION OF FOOD PRODUCTS OF WHICH THE CATIONIC COMPOSITION IS PHYSIOLOGICALLY OPTIMIZED AND PRODUCTS PREPARED ACCORDING TO THIS PROCESS |
USRE31836E (en) * | 1979-05-18 | 1985-02-19 | Efamol Limited | Pharmaceutical and dietary composition |
EP0040654A2 (en) * | 1980-05-20 | 1981-12-02 | Vitapharm Pharmaceutical Pty Ltd. | Electrolyte drink concentrate |
EP0040654A3 (en) * | 1980-05-20 | 1981-12-16 | Vitapharm Pharmaceutical Pty Ltd. | Electrolyte drink concentrate |
EP0595006A1 (en) | 1992-09-14 | 1994-05-04 | Vesta Medicines (Proprietary) Limited | Pharmaceutical and dietary compositions for the treatment and prophylaxis of metabolic disturbances in infants containing vitamin B6, folic acid and vitamin B12 |
US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
US6339085B1 (en) | 1999-03-08 | 2002-01-15 | The University Of Manitoba | Therapeutics for cardiovascular and related diseases |
US7230009B2 (en) | 1999-03-08 | 2007-06-12 | Medicure, Inc. | Pyridoxal analogues and methods of treatment |
US6890943B2 (en) | 1999-03-08 | 2005-05-10 | Medicure Inc. | Pyridoxal analogues and methods of treatment |
GB2353471A (en) * | 1999-07-06 | 2001-02-28 | Daniel Vigdorovich | Composition for treating obesity |
GB2353471B (en) * | 1999-07-06 | 2004-08-18 | Daniel I Vigdorovich | Composition for treating obesity and related disorders and using therof |
US6489345B1 (en) | 1999-07-13 | 2002-12-03 | Medicure, Inc. | Treatment of diabetes and related pathologies |
US6677356B1 (en) | 1999-08-24 | 2004-01-13 | Medicure International Inc. | Treatment of cardiovascular and related pathologies |
US7115626B2 (en) | 1999-08-24 | 2006-10-03 | Medicure International Inc. | Treatment of cardiovascular and related pathologies |
US7144892B2 (en) | 1999-08-24 | 2006-12-05 | Merrill Lynch Capital Canada Inc. | Treatment of cardiovascular and related pathologies |
US7132430B2 (en) | 1999-08-24 | 2006-11-07 | Medicure International Inc. | Treatment of cardiovascular and related pathologies |
US7125889B2 (en) | 1999-08-24 | 2006-10-24 | Medicure International Inc. | Treating of cardiovascular and related pathologies |
US7115625B2 (en) | 1999-08-24 | 2006-10-03 | Medicure International Inc. | Treatment of cardiovascular and related pathologies |
US7105673B2 (en) | 2000-02-29 | 2006-09-12 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
US6667315B2 (en) | 2000-02-29 | 2003-12-23 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
US6867215B2 (en) | 2000-02-29 | 2005-03-15 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
US6780997B2 (en) | 2000-02-29 | 2004-08-24 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
US6605612B2 (en) | 2000-02-29 | 2003-08-12 | Medicure International Inc. | Cardioprotective phosohonates and malonates |
US6861439B2 (en) | 2000-03-28 | 2005-03-01 | Medicure International, Inc. | Treatment of cerebrovascular disease |
US6586414B2 (en) | 2000-03-28 | 2003-07-01 | Medicure International Inc. | Treatment of cerebrovascular disease |
US6897228B2 (en) | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
US6417204B1 (en) | 2000-07-07 | 2002-07-09 | Medicure International Inc. | Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics |
US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
US7812037B2 (en) | 2004-10-28 | 2010-10-12 | Medicure International, Inc. | Dual antiplatelet/anticoagulant pyridoxine analogs |
Also Published As
Publication number | Publication date |
---|---|
NL7605169A (en) | 1976-11-18 |
FR2361878A1 (en) | 1978-03-17 |
DE2621215A1 (en) | 1976-12-02 |
FR2361878B1 (en) | 1979-03-02 |
CA1065672A (en) | 1979-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1493993A (en) | Dietary supplement and dietary methods employing said supplement for the treatment of obesity | |
US4237118A (en) | Dietary supplement and dietary methods employing said supplement for the treatment of obesity | |
ES8702144A1 (en) | Enteral nutritional hypoallergenic formula. | |
ATE73658T1 (en) | DIET SUPPLEMENT TO REDUCE THE RISK OF INFECTION. | |
DK1001685T3 (en) | Food composition containing methionine | |
EP0575846A3 (en) | Food and feedstuff containing lipase inhibitors. | |
WO1996039050A3 (en) | Therapeutic system for dietary health management | |
DE69806820T2 (en) | CALORIOUS NUTRITIONAL COMPOSITION | |
JPS5342283A (en) | Polymer for blood serum separation | |
Satyanarayana et al. | Effect of nutritional deprivation in early childhood on later growth—a community study without intervention | |
EP0130746A3 (en) | Pig feedstuff | |
KR890003392A (en) | Nutritional supplements | |
FR2618305B1 (en) | NUTRITIONAL MIXTURE FOR THE ELDERLY | |
GB1191246A (en) | Vitamin-containing Preparations | |
Fritz et al. | Measurement of the bioavailability of iron, using the rat hemoglobin repletion test | |
JP2970957B2 (en) | Refined pollen nutritional preparation | |
Mraz | Influence of dietary potassium and sodium on cesium-134 and potassium-42 excretion in sheep | |
AU6513386A (en) | Composition to improve cellular metabolism | |
Rader et al. | Copper depletion in Long-Evans rats fed inorganic tin. | |
Carroll | The growth-retarding effect of erucic acid and its relation to requirements for fat-soluble vitamins | |
Willmer et al. | ENZYMATIC AND METABOLIC ADAPTATIONS: I. CHANGES IN INTACT RATS SUBJECTED TO DIETARY MODIFICATIONS | |
TAKEDA et al. | Effects of supplemental dietary oxidized oil and nutrient mixture on lipid peroxidation in red sea bream | |
DE69405742D1 (en) | POLYAMINE NUTRITIONAL AND / OR MEDICINE COMPOSITION | |
Hunt | Potential danger in excess supplements | |
Hashimoto | Protein-Bound Iodine Levels in Children with Nutritional Dystrophy Studies on the Nutrition of Children in Hirosaki Area (26th Report) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19930428 |